These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1858580

  • 1. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
    Yamazaki K, Kumamoto Y, Tsukamoto T, Ohmura K, Miyao N, Yoshioka M, Iwasawa A.
    Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
    [Abstract] [Full Text] [Related]

  • 2. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
    Hoshino M, Fuji K, Kataoka K, Inoue K, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
    [Abstract] [Full Text] [Related]

  • 3. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K, Igarashi T, Tobe T, Mizoguchi K, Suzuki H, Furuya Y, Ichikawa T, Nakatsu HO, Ito H.
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [Abstract] [Full Text] [Related]

  • 4. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
    Sato T, Sakata Y, Tamura K.
    Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma.
    Kawata N, Yamaguchi K, Hirakata H, Hachiya T, Yoshida T, Takimoto Y.
    Urology; 2005 Oct; 66(4):736-40. PubMed ID: 16230127
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
    Okada S, Kirime S, Kawasaki T, Kanbara A, Kanehara H, Takasaki N, Miyazaki S, Inai S.
    Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
    [Abstract] [Full Text] [Related]

  • 7. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
    Shibayama T, Nakazono M, Koyama Y, Deguchi N, Baba S, Jitsukawa S, Murai M, Tazaki H.
    Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M, Yamane T, Kasuga M, Torii T, Imai H, Kageyama N, Fujita Y, Majima S.
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
    Battaglia F, Scambia G, Panici PB, Castelli M, Ferrandina G, Foti E, Amoroso M, D'Andrea G, Mancuso S.
    Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
    Sakamoto J, Teramukai S, Koike A, Saji S, Ohashi Y, Nakazato H.
    Cancer; 1996 Jun 01; 77(11):2206-12. PubMed ID: 8635085
    [Abstract] [Full Text] [Related]

  • 12. [Clinical study on the serum carcinoembryonic antigen, immunosuppressive acidic protein and C-reactive protein levels in patients with adult T cell leukemia].
    Kumagai E, Ogata M, Maeda Y, Kumagai T, Okajima K, Yamaguchi K, Tanoue S.
    Rinsho Byori; 1989 Jul 01; 37(7):769-73. PubMed ID: 2607647
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
    Ogoshi K, Kondoh Y, Nakasaki H, Tajima T, Mitomi T.
    Gan No Rinsho; 1983 Aug 01; 29(9):987-90. PubMed ID: 6688640
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M, Saito K, Iimura Y, Fujii Y, Kawakami S, Kihara K.
    J Urol; 2008 Aug 01; 180(2):515-9. PubMed ID: 18550105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
    Nishio S, Ozaki Y, Wada S, Kawakita J, Maekawa M.
    Hinyokika Kiyo; 1984 Apr 01; 30(4):449-57. PubMed ID: 6485956
    [Abstract] [Full Text] [Related]

  • 19. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
    Kondo H, Seno N, Matsuo S, Otagaki S, Matsuki T, Hatayama T.
    Gan To Kagaku Ryoho; 1983 Oct 01; 10(10):2163-70. PubMed ID: 6625623
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
    Koebl H, Tatra G, Bieglmayer C.
    Neoplasma; 1988 Oct 01; 35(2):215-20. PubMed ID: 3259680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.